irinotecan has been researched along with dronabinol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brčić Karačonji, I; Čanović, S; Fuchs, N; Jurič, A; Kopjar, N; Lucić Vrdoljak, A; Micek, V; Mikolić, A; Mršić, G; Neuberg, M; Prester, L; Žunec, S | 1 |
| Brajenović, N; Fuchs, N; Fuchs, R; Karačonji, IB; Katić, A; Micek, V; Miljanić, A | 1 |
| Brčić Karačonji, I; Fuchs, N; Katić, A; Kopjar, N; Kozina, G; Lucić Vrdoljak, A; Žunec, S | 1 |
| Čatalinac, M; Jurič, A; Karačonji, IB; Katić, A; Kozina, G; Micek, V; Neuberg, M; Vrdoljak, AL; Žunec, S | 1 |
2 review(s) available for irinotecan and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
High Doses of Δ
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Humans; Irinotecan; Topoisomerase I Inhibitors | 2020 |
6 other study(ies) available for irinotecan and dronabinol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Irinotecan and Δ⁸-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biomarkers; Body Weight; Camptothecin; DNA Damage; Dose-Response Relationship, Drug; Dronabinol; Irinotecan; Liver; Liver Function Tests; Male; Mutagenicity Tests; Organ Size; Oxidative Stress; Rats, Wistar | 2018 |
Optimisation of a gas chromatography-mass spectrometry method for the simultaneous determination of tetrahydrocannabinol and its metabolites in rat urine.
Topics: Animals; Dronabinol; Gas Chromatography-Mass Spectrometry; Irinotecan; Male; Rats; Solid Phase Extraction; Topoisomerase I Inhibitors | 2019 |
Effects of concomitant use of THC and irinotecan on tumour growth and biochemical markers in a syngeneic mouse model of colon cancer.
Topics: Animals; Biomarkers; Colonic Neoplasms; Dronabinol; Humans; Irinotecan; Male; Mice; Quality of Life | 2023 |